Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Insmed Inc.

Start price
Target price
Perf. (%)
€43.00
29.05.24
€50.69
29.05.25
40.70%
17.06.24

JPMorgan Chase & Co. 
29.05.24 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€41.20
28.05.24
€36.78
28.05.25
46.84%
17.06.24

Bank of America Co. 
28.05.24 50%
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.14
28.05.24
€8.28
28.05.25
-18.11%
08:02

HC Wainwright 
28.05.24 50%
sell
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€33.60
28.05.24
€29.42
28.05.25
-1.79%
17.06.24

The Goldman Sachs Group, Inc. 
28.05.24 50%
buy
Allscripts Healthcare

Start price
Target price
Perf. (%)
€7.00
28.05.24
€13.79
28.05.25
21.43%
17.06.24

TD Cowen 
28.05.24 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€69.50
28.05.24
€87.33
28.05.25
2.88%
18:54

Argus 
28.05.24 50%
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.14
28.05.24
€11.03
28.05.25
-18.11%
08:02

Needham & Company LLC 
28.05.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€4.10
28.05.24
€16.08
28.05.25
-20.49%
17.06.24

HC Wainwright 
28.05.24 50%
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€363.80
28.05.24
€399.77
28.05.25
3.16%
18:49

Mizuho 
28.05.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€4.10
28.05.24
€14.70
28.05.25
-20.49%
17.06.24

Royal Bank of Canada 
28.05.24 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€129.45
28.05.24
€177.37
28.05.25
-2.55%
19:11

UBS Group AG 
28.05.24 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€20.40
28.05.24
€38.00
30.06.26
109.80%
28.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
28.05.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€422.00
27.05.24
-
27.05.25
3.71%
18:47

StockNews.com 
27.05.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€422.00
27.05.24
-
27.05.25
3.71%
18:47

StockNews.com 
27.05.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€422.00
27.05.24
-
27.05.25
3.71%
18:47

StockNews.com 
27.05.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.18
26.05.24
€4.00
31.01.26
-17.03%
12.06.24

Could be very worthwhile Investment >20% year
BiotechBee 
26.05.24 50%
sell
Insmed Inc.

Start price
Target price
Perf. (%)
€20.40
26.05.24
€16.00
31.01.26
0.00%
28.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
26.05.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€14.19
26.05.24
-
26.05.25
19.87%
08.06.24

Could be worthwhile Investment >10% per year
melinda 
26.05.24 0%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
26.05.24
-
26.05.25
-
23.09.22

StockNews.com 
26.05.24 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
26.05.24
-
26.05.25
-
23.12.22

StockNews.com 
26.05.24 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€5.95
26.05.24
-
26.05.25
-0.84%
17.06.24

StockNews.com 
26.05.24 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.16
26.05.24
-
26.05.25
47.22%
17.06.24

StockNews.com 
26.05.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.17
26.05.24
-
26.05.25
5.40%
08.06.24

Could be worthwhile Investment >10% per year
daimler1 
26.05.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€14.19
25.05.24
€142.00
25.05.25
19.87%
08.06.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
mixitrader 
25.05.24 50%
buy
Quest Diagnostics Inc.

Start price
Target price
Perf. (%)
€130.00
25.05.24
-
25.05.25
-1.12%
09:30

StockNews.com 
25.05.24 50%